(Q40561645)

21 September 2017

Standardization and statistical approaches to therapeutic trials in the R6/2 mouse (English)

1 reference

21 September 2017

0 references

4

1 reference

21 September 2017

5

1 reference

21 September 2017

Emma Hockly

1

1 reference

PubMed ID

13679245

21 September 2017

Benjamin Woodman

series ordinal

2

1 reference

PubMed ID

13679245

21 September 2017

Amarbirpal Mahal

series ordinal

3

1 reference

21 September 2017

1 September 2003

1 reference

21 September 2017

Brain Research Bulletin

1 reference

21 September 2017

61

1 reference

21 September 2017

5

1 reference

21 September 2017

469-479

1 reference

Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Controlling the false discovery rate in behavior genetics research

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

More powerful procedures for multiple significance testing

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Environmental enrichment slows disease progression in R6/2 Huntington's disease mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Environmental stimulation of 129/SvJ mice causes increased cell proliferation and neurogenesis in the adult dentate gyrus

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Neurological abnormalities in a knock-in mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

EDF Statistics for Goodness of Fit and Some Comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Neural consequences of environmental enrichment

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900185-0

7 January 2021

10.1016/S0361-9230(03)00185-0

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

13679245